1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study
HAIDER S, PARKER M, HUANG E, GRANT R, MOFFET H, LAITEERAPONG N, LIU J, LIPSKA K, KARTER A. 1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study. Diabetes 2023, 72 DOI: 10.2337/db23-1217-p.Peer-Reviewed Original ResearchType 2 diabetesOlder patientsKaiser Permanente Northern CaliforniaDe-intensify treatmentDuration of diabetesGlucose-lowering medicationsNumber of medicationsProportion of patientsClinical guideline recommendationsHealth status factorsPoor health statusCross-sectional analysisInsulin useComplex regimensLess medicationGuideline recommendationsPatients' willingnessAbbVie Inc.Side effectsDiabetesPatient experiencePatientsHealth statusHypoglycemia historyMedications1356-P: Association of HbA1c with Diabetes Outcomes across Health Status Categories in Older Adults
LIPSKA K, HUANG E, LIU J, PARKER M, MOFFET H, GRANT R, LAITEERAPONG N, KARTER A. 1356-P: Association of HbA1c with Diabetes Outcomes across Health Status Categories in Older Adults. Diabetes 2023, 72 DOI: 10.2337/db23-1356-p.Peer-Reviewed Original ResearchComplication riskPoor healthIntermediate healthOlder adultsGood healthIntegrated healthcare delivery systemAssociation of HbA1cType 2 diabetesProportional hazards modelNational InstituteHealth status categoriesHealthcare delivery systemEligible patientsMacrovascular eventsSevere hypoglycemiaKidney diseaseClinical variablesDiabetes outcomesEndocrine SocietyAbbVie Inc.Hazards modelComplicationsHealth statusTwin healthPatients